Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Upper GI Series: Barium Swallow01:24

Upper GI Series: Barium Swallow

The Barium Swallow Study, or a Barium Esophagogram, is a diagnostic imaging method used to visualize the upper gastrointestinal (GI) tract, including the esophagus, stomach, and small intestine. It employs barium sulfate, a radiopaque contrast material, to provide clear images of the upper digestive system, helping to identify abnormalities, diseases, or structural issues.
Purpose and Procedure
Patients undergoing this procedure ingest a liquid containing barium sulfate with a chalky...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemotherapy for patients with circulating tumour DNA-positive, stage II colon cancer (CIRCULATE)-an AIO/ABCSG trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Tracing TET1 expression in prostate cancer: discovery of malignant cells with a distinct oncogenic signature.

Clinical epigenetics·2021
Same author

Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.

Virchows Archiv : an international journal of pathology·2018
Same author

Management of patients with pancreatic cystic lesions: A case-based survey.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2017
Same author

[University Pathology in Germany].

Der Pathologe·2017
Same author

[Current biomarkers for gastric cancer].

Der Pathologe·2017
Same journal

[Connective (tissue) pathology: What brings us together!]

Der Pathologe·2022
Same journal

[Giant cell-containing tumors of bone and differential diagnoses].

Der Pathologe·2022
Same journal

[Automation and application of robotics in the pathology laboratory].

Der Pathologe·2022
Same journal

[Practical diagnostic aspects of uterine leiomyosarcoma in the context of the 2020 WHO classification].

Der Pathologe·2022
Same journal

[Artificial intelligence: a solution for the lack of pathologists?]

Der Pathologe·2022
Same journal

[Predictive immunocytochemistry in non-small cell lung carcinoma].

Der Pathologe·2022
See all related articles

Related Experiment Video

Updated: May 25, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

[Barrett's esophagus. An update].

G B Baretton1, D E Aust

  • 1Institut für Pathologie, Universitätsklinikum Carl Gustav Carus, TU Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland. Gustavo.Baretton@uniklinikum-dresden.de

Der Pathologe
|February 2, 2012
PubMed
Summary
This summary is machine-generated.

Barrett's esophagus, a precancerous condition linked to GERD, shows a less dramatic incidence rise than previously thought. Accurate diagnosis of dysplasia is crucial for managing Barrett's adenocarcinoma risk.

More Related Videos

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

Surgical Models of Gastroesophageal Reflux with Mice
05:19

Surgical Models of Gastroesophageal Reflux with Mice

Published on: August 25, 2015

Related Experiment Videos

Last Updated: May 25, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

Surgical Models of Gastroesophageal Reflux with Mice
05:19

Surgical Models of Gastroesophageal Reflux with Mice

Published on: August 25, 2015

Area of Science:

  • Gastroenterology and Oncology
  • Histopathology

Context:

  • Barrett's esophagus (BE) is a complication of GERD and a precursor to esophageal adenocarcinoma.
  • Incidence trends for Barrett's carcinoma are being re-evaluated, with recent data suggesting a less dramatic rise than previously assumed.
  • Diagnostic criteria for BE, particularly the requirement for goblet cells, are evolving, with ongoing debate between endoscopic and histological definitions.

Purpose:

  • To review the current understanding and diagnostic challenges of Barrett's esophagus and associated dysplasia.
  • To highlight the significance of dysplastic changes as a risk factor for Barrett's adenocarcinoma.
  • To discuss the subclassification of dysplasia and diagnostic methodologies.

Summary:

  • Dysplastic changes in the esophageal epithelium are the primary risk factor for Barrett's adenocarcinoma.
  • Dysplasia is subclassified into adenomatous (intestinal) and non-adenomatous (gastric-foveolar) types.
  • Hematoxylin and eosin (H&E) staining remains the gold standard for diagnosing dysplasia, but significant interobserver variability exists, especially in differentiating low-grade dysplasia from reactive changes and high-grade dysplasia from adenocarcinoma.
  • Interobserver agreement is higher in endoscopic resection specimens compared to biopsies.
  • External second opinions are recommended for histological dysplasia diagnosis due to clinical implications.
  • Pathological reports for early Barrett's adenocarcinoma resections must include risk stratification for lymph node metastasis.

Impact:

  • Improved diagnostic accuracy for Barrett's esophagus and dysplasia can lead to better patient management and risk stratification.
  • Addressing interobserver variability in dysplasia diagnosis is crucial for consistent clinical decision-making.
  • Standardized reporting of risk stratification in early esophageal adenocarcinoma resections can guide treatment strategies and improve patient outcomes.